Medicine & Health

WashU Medicine researchers have found that cells originating in bone and normally involved in bone formation are recruited to primary breast tumors, where they become part of the tumor microenvironment and may play a role in supporting tumor growth.

WashU Medicine researchers discovered that while rates of mammography screening remained steady in the overall population over two decades, they fell significantly among younger white women, uninsured women and current smokers.

WashU Medicine researchers have developed a technique to synthesize shape-shifting “disordered proteins,” creating new opportunities to understand the basis of disease and design potential medical interventions.

Biomedical engineers at WashU have created a new platform to study mechanobiology, which can help with research on cancer and fibrosis.

Yin Cao, ScD, an associate professor in the Division of Public Health Sciences in the WashU Medicine Mary Culver Department of Surgery, has been named a 2026 Fellow of the 101st class of the John Simon Guggenheim Memorial Foundation.

WashU Medicine researchers have shown in mice that a medication-design technique in which modular components of anti-cancer drugs are administered separately and assembled in the body — using what’s known as “click chemistry” — is more effective than standard treatments at targeting and shrinking tumors.

WashU biomedical engineer Yifan Dai will study chemical processes in cells thanks to a $2 million NIH grant.

Biomedical engineer Quing Zhu and WashU Medicine collaborators combined optical coherence tomography and machine learning for a rapid, accurate test for endometrial cancer.

A new study led by researchers at WashU Medicine suggests that younger generations are aging biologically faster than their older counterparts. This faster biological aging (represented by the right red clock) was also linked to early-onset cancers.

At the WashU Office of Technology Management’s annual Celebration of Inventors, WashU Medicine researchers Graham Colditz and Shu (Joy) Jiang were honored for developing and commercializing a technology to predict breast cancer risk.